Literature DB >> 8945890

Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel.

B T Liang1.   

Abstract

Both adenosine receptor and ATP-sensitive K (KATP) channel mediate the protective effect of ischemic preconditioning in the intact heart. The objective of the present study was to determine the role of adenosine receptor and KATP channel as well as their interaction in simulating and mediating preconditioning of the cardiac myocyte. Cardiac ventricular myocytes cultured from chick embryos 14 days in ovo were developed as a myocyte model of preconditioning. Myocytes were preconditioned by exposing them to 5-min hypoxia, termed preconditioning hypoxia, before a second 90-min hypoxia. Preconditioning resulted in a 64 +/- 3% decrease in the amount of creatine kinase released and a 66 +/- 2% reduction in the percentage of myocytes (+/-SE, n = 11) killed. Glibenclamide or 5-hydroxydecanoic acid (5-HD), when present during the preconditioning hypoxia, blocked the preconditioning effect. Prior exposure of the myocytes to pinacidil also led to a decrease in the injury sustained during the 90-min hypoxia. The protective effect of pinacidil was blocked by glibenclamide or 5-HD, suggesting that KATP channel activation can mimic as well as mediate preconditioning. Adenosine receptor antagonist 8-sulfophenyltheophylline (8-SPT) blocked the protective effect of preconditioning hypoxia. Adenosine or the A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA) can replace preconditioning hypoxia and mimic preconditioning; this effect was fully antagonized by 8-SPT, glibenclamide, or 5-HD. Adenosine A1-receptor activation caused a glibenclamide-sensitive inhibition of the basal 45Ca influx and basal myocyte contractile amplitude, consistent with coupling of A1 receptor to stimulation of KATP channel in the myocytes. The data provide direct evidence that myocyte KATP channel is the effector downstream from adenosine A1 receptor in mediating the direct preconditioning of cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945890     DOI: 10.1152/ajpheart.1996.271.5.H1769

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Cardiac ion channels.

Authors:  Birgit T Priest; Jeff S McDermott
Journal:  Channels (Austin)       Date:  2015-08-20       Impact factor: 2.581

Review 2.  Neoceptors: reengineering GPCRs to recognize tailored ligands.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Bruce T Liang
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

3.  Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.

Authors:  M Parsons; L Young; J E Lee; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

4.  Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver.

Authors:  Filipe V Duarte; João A Amorim; Ana T Varela; João S Teodoro; Ana P Gomes; Rodrigo A Cunha; Carlos M Palmeira; Anabela P Rolo
Journal:  Purinergic Signal       Date:  2016-11-15       Impact factor: 3.765

5.  A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.

Authors:  K A Jacobson; R Xie; L Young; L Chang; B T Liang
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

6.  A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.

Authors:  K Stambaugh; K A Jacobson; J L Jiang; B T Liang
Journal:  Am J Physiol       Date:  1997-07

7.  Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels.

Authors:  Mohammed A Nayeem; G Paul Matherne; S Jamal Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-25       Impact factor: 3.000

8.  Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor.

Authors:  C Dougherty; J Barucha; P R Schofield; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

9.  A physiological role of the adenosine A3 receptor: sustained cardioprotection.

Authors:  B T Liang; K A Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: implications for ischemic preconditioning.

Authors:  Andrew P Wojtovich; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2008-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.